Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Protagonist Therapeutics, Inc](/topic/$ptgx)

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$ptgx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$ptgx/time-series/close.tsv)  
The price is currently near a 52-week high, driven by positive clinical trial results, increased social engagement, and the potential acquisition by Johnson & Johnson. The positive news has led to increased trading volume and a surge in social media mentions, further supporting the price increase.  

| 24-Hour | 7-Day   | 30-Day |
| ------- | -----   | ------ |
| XXXX%   | -XXXXX% | XXXX%  |

**1-Year High**: $XX on 2025-10-10  
**1-Year Low**: $XXXXX on 2025-02-25

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Protagonist Therapeutics, Inc

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The price is currently near a 52-week high, driven by positive clinical trial results, increased social engagement, and the potential acquisition by Johnson & Johnson. The positive news has led to increased trading volume and a surge in social media mentions, further supporting the price increase.

24-Hour 7-Day 30-Day
XXXX% -XXXXX% XXXX%

1-Year High: $XX on 2025-10-10
1-Year Low: $XXXXX on 2025-02-25

Protagonist Therapeutics, Inc (PTGX) Price
/topic/$ptgx/close